Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment Strategies

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Treatment and Issues For Triple Negative Breast Cancer-May 14, 2020Подробнее

Novel Strategies for HER2+ Metastatic Breast Cancer; BiosimilarsПодробнее

Treatment strategies for HER2+ metastatic breast cancerПодробнее

Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, TargetsПодробнее

Improving the Management of Metastatic Breast Cancer: Novel and Emerging Treatments, Part IПодробнее

New and emerging agents in HER2-negative metastatic breast cancer: Implications for practiceПодробнее

Emerging immunotherapy beyond checkpoint inhibitors for TNBCПодробнее

Exploring novel strategies for breast cancer treatmentПодробнее

Novel strategies for endocrine therapy: Can we do better?Подробнее

AMEERA-3: SERD for ER+ HER2- breast cancerПодробнее

Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast CancerПодробнее

Novel Combo Promising in Advanced HER2-Negative Breast Cancer - Medpage TodayПодробнее

Management of premenopausal HR+/HER2- breast cancer with micro-metastasisПодробнее

Vandana Abramson, MD, Addresses Treatment Strategies for Metastatic Breast CancerПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее

Novel Strategies for Treatment of Early Breast Cancer, Part IПодробнее

Novel Approaches for HER2-Negative Metastatic Breast CancerПодробнее

New FDA-Approved Targeted Drug for Treatment-Resistant, ER Positive HER2 Negative Breast CancerПодробнее

Integrating Novel Developments for Advanced and Metastatic Breast Cancer into Improved Care PathwaysПодробнее